(Q74467049)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9553669%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

A phase II study of oral clofazimine in unresectable and metastatic hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9553669%20AND%20SRC:MED&resulttype=core&format=json

metastatic hepatocellular carcinoma

11 November 2019

main subject

1 reference

1 reference

Constance E Jansen van Rensburg

1 reference

ORCID Public Data File 2021

author name string

P Ruff

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9553669%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

M R Chasen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9553669%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J E Long

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9553669%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

C E van Rensburg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9553669%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 February 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9553669%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9553669%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9553669%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9553669%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

217-219

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9553669%20AND%20SRC:MED&resulttype=core&format=json

Prognosis of primary hepatocellular carcinoma

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008204911774

7 January 2021

Clinical trials in primary hepatocellular carcinoma: current status and future directions

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008204911774

7 January 2021

Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008204911774

7 January 2021

A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008204911774

7 January 2021

Anti-Tubercular Activity of Oxidation Products of Substituted o-Phenylene Diamines

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008204911774

7 January 2021

Clinical pharmacokinetics of clofazimine. A review

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008204911774

7 January 2021

Identifiers

DOI

10.1023/A:1008204911774

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9553669%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference